Company Loxo Oncology Inc
Equities
US5488621013
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 39 | 14-04-30 | |
President | - | - | |
Anthony Sireci
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Liz Beja
COO | Chief Operating Officer | - | - |
David Hyman
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Compliance Officer | - | 18-03-31 | |
Human Resources Officer | - | - | |
Amy Rose
HRO | Human Resources Officer | - | 19-12-31 |
Philip Johnson
LAW | General Counsel | - | 20-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,614,536 | 29,481,314 ( 96.30 %) | 0 | 96.30 % |
Company contact information
Loxo Oncology, Inc.
281 Tresser Boulevard 9th floor
06901, Stamford
+203-653-3880
http://www.loxooncology.comSector
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.99% | 22.02B | |
-17.84% | 20.9B | |
-8.93% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |